Epidermal Growth Factor Intralesional Delivery in Chronic Wounds: The Pioneer and Standalone Technique for Reversing Wound Chronicity and Promoting Sustainable Healing
Jorge Berlanga‐Acosta(Centro de Ingeniería Genética y Biotecnología), Elof Eriksson(Applied Tissue Technologies (United States)), Merardo Pujol(Centro de Ingeniería Genética y Biotecnología), Nelson Acosta‐Rivero(University of Havana), José I Fernández‐Montequín(Instituto de Gastroenterología), Miladys Limonta‐Fernández(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Viviana Falcón‐Cama(Centro de Ingeniería Genética y Biotecnología), Marta Ayala‐Ávila(Centro de Ingeniería Genética y Biotecnología), Ariana García‐Ojalvo(Centro de Ingeniería Genética y Biotecnología)
Cited by 17
Related Papers
Chronic wounds: Treatment consensus
|Wound Repair and Regeneration|2022|389
The effect of pH on cell viability, cell migration, cell proliferation, wound closure, and wound reepithelialization: In vitro and in vivo study
|Wound Repair and Regeneration|2017|252
Dry, Moist, and Wet Skin Wound Repair
|Annals of Plastic Surgery|1995|175
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167